Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing MT1988 Low Dose with placebo for people with Clinical High Risk for Psychosis. Participants receive MT1988 Low Dose or placebo and complete study visits and assessments.
This observational study is following people with Alzheimer's Disease Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether cognitive behavioural therapy can help people with Clinical High-Risk or Psychological. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at care and outcomes for people with Social anxiety. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR). Participants take part in the program and complete follow-up questionnaires or assessments.
This study is comparing ITI-1284 with placebo for people with Psychosis Associated With Alzheimer's Disease. Participants receive ITI-1284 or placebo and complete study visits and assessments.
This study is looking at whether psychoeducation can help people with Caregiver, Caregiver Distress, Caregiver to a Young With Early Psychosis, or Family Caregivers. Participants take part in psychoeducation and complete follow-up assessments.
This observational study is following people with Alzheimer Disease, Dementia Alzheimers, Dementia, or Cognitive Impairment to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing AGB101 with placebo for people with Parkinson Disease Psychosis. Participants receive AGB101 or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Opioid Use Disorder, Dual Diagnosis, Housing Problems, or Mental Disorder in Adolescence. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether Healthy ReStart can help people with Mental Disorder. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with Parkinson's Disease Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Semaglutide Pen Injector with placebo for people with Opioid Use Disorder, Opioid Abuse and Addiction, Narcotic-Related Disorders, or Substance-Related Disorders. Participants receive Semaglutide Pen Injector or placebo and complete study visits and assessments.
This study is looking at whether Pimavanserin can help people with Neurodegenerative Diseases, Parkinson Disease, or Parkinson Disease Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with Autism, Challenging Behavior, Adhd, or Oppositional Defiant Disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether Extended-Release Methylphenidate can help people with Sickle Cell Disease, Executive Dysfunction, Cognitive Impairment, or Attention Deficit/Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Attention Deficit Hyperactivity Disorder, Sleep, or Physical Activity. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with Attention Deficit Hyperactivity Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Child Behavior Problem or Attention Deficit and Disruptive Behavior Disorders. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Stasis Daytime and Nighttime with placebo for people with Adhd, Sleep Disturbance, or Brain Fog. Participants receive Stasis Daytime and Nighttime or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Adhd. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether Meta Quest 3 VR Headset with noise cancelling headphones can help people with Attention Deficit Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Active repetitive TMS can help people with Attention Deficit Hyperactivity Disorder. Participants take part in Active repetitive TMS and complete follow-up assessments.
This study is looking at evaluate the ability of methylphenidate to treat PTSD and associated neurocognitive complaints in Veterans for people with Posttraumatic Stress Disorder. Participants receive Methylphenidate or placebo and complete study visits and assessments.